Cargando…

Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role

Membranous nephropathy (MN) is the major cause of nephrotic syndrome with special pathological features, caused by the formation of immune complexes in the space between podocytes and the glomerular basement membrane. In idiopathic membranous nephropathy (IMN) the immune complexes are formed by circ...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wenbin, Gao, Chang, Dai, Haoran, Zheng, Yang, Dong, Zhaocheng, Gao, Yu, Liu, Fei, Zhang, Zihan, Liu, Zhiyuan, Liu, Weijing, Liu, Baoli, Liu, Qingquan, Shi, Jialan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691064/
https://www.ncbi.nlm.nih.gov/pubmed/31447839
http://dx.doi.org/10.3389/fimmu.2019.01809
_version_ 1783443289049923584
author Liu, Wenbin
Gao, Chang
Dai, Haoran
Zheng, Yang
Dong, Zhaocheng
Gao, Yu
Liu, Fei
Zhang, Zihan
Liu, Zhiyuan
Liu, Weijing
Liu, Baoli
Liu, Qingquan
Shi, Jialan
author_facet Liu, Wenbin
Gao, Chang
Dai, Haoran
Zheng, Yang
Dong, Zhaocheng
Gao, Yu
Liu, Fei
Zhang, Zihan
Liu, Zhiyuan
Liu, Weijing
Liu, Baoli
Liu, Qingquan
Shi, Jialan
author_sort Liu, Wenbin
collection PubMed
description Membranous nephropathy (MN) is the major cause of nephrotic syndrome with special pathological features, caused by the formation of immune complexes in the space between podocytes and the glomerular basement membrane. In idiopathic membranous nephropathy (IMN) the immune complexes are formed by circulating antibodies binding mainly to one of two naturally-expressed podocyte antigens: the M-type receptor for secretory phospholipase A2 (PLA2R1) and the Thrombospondin type-1 domain-containing 7A (THSD7A). Formation of antibodies against PLA2R1 is much more common, accounting for 70–80% of IMN. However, the mechanism of anti-podocyte antibody production in IMN is still unclear. In this review, we emphasize that the exposure of PLA2R1 is critical for triggering the pathogenesis of PLA2R1-associated MN, and propose the potential association between inflammation, pollution and PLA2R1. Our review aims to clarify the current research of these precipitating factors in a way that may suggest future directions for discovering the pathogenesis of MN, leading to additional therapeutic targets and strategies for the prevention and early treatment of MN.
format Online
Article
Text
id pubmed-6691064
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-66910642019-08-23 Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role Liu, Wenbin Gao, Chang Dai, Haoran Zheng, Yang Dong, Zhaocheng Gao, Yu Liu, Fei Zhang, Zihan Liu, Zhiyuan Liu, Weijing Liu, Baoli Liu, Qingquan Shi, Jialan Front Immunol Immunology Membranous nephropathy (MN) is the major cause of nephrotic syndrome with special pathological features, caused by the formation of immune complexes in the space between podocytes and the glomerular basement membrane. In idiopathic membranous nephropathy (IMN) the immune complexes are formed by circulating antibodies binding mainly to one of two naturally-expressed podocyte antigens: the M-type receptor for secretory phospholipase A2 (PLA2R1) and the Thrombospondin type-1 domain-containing 7A (THSD7A). Formation of antibodies against PLA2R1 is much more common, accounting for 70–80% of IMN. However, the mechanism of anti-podocyte antibody production in IMN is still unclear. In this review, we emphasize that the exposure of PLA2R1 is critical for triggering the pathogenesis of PLA2R1-associated MN, and propose the potential association between inflammation, pollution and PLA2R1. Our review aims to clarify the current research of these precipitating factors in a way that may suggest future directions for discovering the pathogenesis of MN, leading to additional therapeutic targets and strategies for the prevention and early treatment of MN. Frontiers Media S.A. 2019-08-06 /pmc/articles/PMC6691064/ /pubmed/31447839 http://dx.doi.org/10.3389/fimmu.2019.01809 Text en Copyright © 2019 Liu, Gao, Dai, Zheng, Dong, Gao, Liu, Zhang, Liu, Liu, Liu, Liu and Shi. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Liu, Wenbin
Gao, Chang
Dai, Haoran
Zheng, Yang
Dong, Zhaocheng
Gao, Yu
Liu, Fei
Zhang, Zihan
Liu, Zhiyuan
Liu, Weijing
Liu, Baoli
Liu, Qingquan
Shi, Jialan
Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role
title Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role
title_full Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role
title_fullStr Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role
title_full_unstemmed Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role
title_short Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role
title_sort immunological pathogenesis of membranous nephropathy: focus on pla2r1 and its role
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691064/
https://www.ncbi.nlm.nih.gov/pubmed/31447839
http://dx.doi.org/10.3389/fimmu.2019.01809
work_keys_str_mv AT liuwenbin immunologicalpathogenesisofmembranousnephropathyfocusonpla2r1anditsrole
AT gaochang immunologicalpathogenesisofmembranousnephropathyfocusonpla2r1anditsrole
AT daihaoran immunologicalpathogenesisofmembranousnephropathyfocusonpla2r1anditsrole
AT zhengyang immunologicalpathogenesisofmembranousnephropathyfocusonpla2r1anditsrole
AT dongzhaocheng immunologicalpathogenesisofmembranousnephropathyfocusonpla2r1anditsrole
AT gaoyu immunologicalpathogenesisofmembranousnephropathyfocusonpla2r1anditsrole
AT liufei immunologicalpathogenesisofmembranousnephropathyfocusonpla2r1anditsrole
AT zhangzihan immunologicalpathogenesisofmembranousnephropathyfocusonpla2r1anditsrole
AT liuzhiyuan immunologicalpathogenesisofmembranousnephropathyfocusonpla2r1anditsrole
AT liuweijing immunologicalpathogenesisofmembranousnephropathyfocusonpla2r1anditsrole
AT liubaoli immunologicalpathogenesisofmembranousnephropathyfocusonpla2r1anditsrole
AT liuqingquan immunologicalpathogenesisofmembranousnephropathyfocusonpla2r1anditsrole
AT shijialan immunologicalpathogenesisofmembranousnephropathyfocusonpla2r1anditsrole